Ads
    Related conference
  1. A Preliminary Phase-2 Study with very High-Dose of Melatonin (1000 mg/day) in Untreatable Advanced Cancer Patients Already Progression on Previous Palliative Therapy with High-Dose Melatonin
  2. A Short-Period Therapy with Subcutaneous Low-Dose IL-2 Plus High-Dose Melatonin to Correct Advanced Cancer-Related Lymphocytopenia: Possible Impact on the Survival Time
  3. Treatment of Advanced Cancer-related Lymphocytopenia: Comparison among the Effects of Subcutaneous Low-dose Interleukin-2, High-dose Pineal Hormone Melatonin and Checkpoint Inhibitors
  4. Evaluation of Quality of Life of Well Differentiated Thyroid Carcinoma Patients at Baseline and Six Months after Low Dose versus High Dose Radioactive Iodine-131 Ablation
  5. Low-dose and high-dose naltrexone in opioid dependence syndrome: a three months outcome study
  6. HIGH DOSE RATE BRACHYTHERAPY IN THE TREATMENT OF CERVICAL CANCER: RETROSPECTIVE STUDY ABOUT 380 PATIENTS, EXPERIENCE OF THE NATIONAL INSTITUTE OF ONCOLOGY, RABAT
  7. Safety, Feasibility, and Biomarker Effects of High-Dose Vitamin D Supplementation Among Women at High Risk for Breast Cancer - Special Issue
  8. A Prospective Phase III Open Label Study Comparing Low Dose Paclitaxel Versus Cisplatin as Weekly Regimen with Concurrent Radiation in Locally Advanced Head and Neck Cancer
  9. Dose-Related Effects of Melatonin on Human Osteoblastic Cells via in vitro Controlled Release from Nanoscale Calcium Sulfate
  10. Dose distributions verification for High dose rate brachytherapy plans by using ionization chambers 2D array